Table 1 Patient and disease characteristics at start of etanercept (nā€Š=ā€Š146)
Characteristicsn (%)
Median age (years)11.2
Female101 (69)
Male45 (31)
Onset JIA subtype:
Systemic39 (27)
Polyarticular rheumatoid factor positive11 (8)
Polyarticular rheumatoid factor negative55 (38)
Oligoarticular extended28 (19)
Enthesitis related arthritis5 (3)
Juvenile arthritis psoriatica8 (5)
Unclassified0 (0)
Median JIA disease duration (years)4.1
History of drug use before start of etanercept:
NSAIDs141 (97)
Glucocorticoids systemic90 (62)
Glucocorticoids intra-articular60 (41)
MTX146 (100)
Other DMARDS74 (51)
Use of other concomitant drugs at start of etanercept:
NSAIDs122 (84)
Glucocorticoids67 (46)
MTX113 (77)
Other DMARDS13 (9)
  • DMARD, disease-modifying antirheumatic drug; JIA, juvenile idiopathic arthritis; MTX, methotrexate; NSAID, non-steroidal anti-inflammatory drug.